Snapshot

The Verification Review (Type 1) pathway has been developed by the Zambia Medicines Regulatory Authority of Zambia.

This pathway can be used where This pathway is for WHO-prequalified and SRA-approved products..

This pathway accelerates the regulatory review process.

It is a verification review (a recognition pathway).

When relevant, the agency relies on prior decisions from Australia Brazil Canada China EU-EMA Japan Mexico Saudi Arabia Singapore South Korea Switzerland Taiwan (Chinese Taipei) Turkey United Kingdom United States WHO Zazibona

The target time for assessment is 90 calendar days for verification review (Type 1).